Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Svensson

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Ecology|August 4, 2015
Limiting resources in sessile systems: food enhances diversity and growth of suspension feeders despite available spaceRobin J Svensson, Dustin J Marshall
CPT: Pharmacometrics & Systems Pharmacology|July 19, 2022
Efficient and relevant stepwise covariate model building for pharmacometricsRobin J Svensson, E Niclas Jonsson
The Journal of Antimicrobial Chemotherapy|May 19, 2017
Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methodsRobin J Svensson, Stephen H Gillespie, Ulrika S H Simonsson
Antimicrobial Agents and Chemotherapy|March 4, 2020
Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in PatientsAlan Faraj, Robin J Svensson, Andreas H Diacon, et al.
Scientific Reports|September 24, 2020
Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictionsAlan Faraj, Oskar Clewe, Robin J Svensson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band DosingBudi O Susanto, Robin J Svensson, Elin M Svensson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 4, 2022
Rituximab pharmacokinetic and pharmacokinetic-pharmacodynamic evaluation based on a study in diffuse large B-cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarityRobin J Svensson, Qing Xi Ooi, Lena E Friberg, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosisRobin J Svensson, Katarina Niward, Lina Davies Forsman, et al.
Clinical Pharmacology and Therapeutics|June 28, 2017
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin DosesRobin J Svensson, Rob E Aarnoutse, Andreas H Diacon, et al.
Clinical Pharmacology and Therapeutics|April 28, 2018
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With RifampicinSebastian G Wicha, Oskar Clewe, Robin J Svensson, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Ecology|August 4, 2015
Limiting resources in sessile systems: food enhances diversity and growth of suspension feeders despite available spaceRobin J Svensson, Dustin J Marshall
CPT: Pharmacometrics & Systems Pharmacology|July 19, 2022
Efficient and relevant stepwise covariate model building for pharmacometricsRobin J Svensson, E Niclas Jonsson
The Journal of Antimicrobial Chemotherapy|May 19, 2017
Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methodsRobin J Svensson, Stephen H Gillespie, Ulrika S H Simonsson
Antimicrobial Agents and Chemotherapy|March 4, 2020
Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in PatientsAlan Faraj, Robin J Svensson, Andreas H Diacon, et al.
Scientific Reports|September 24, 2020
Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictionsAlan Faraj, Oskar Clewe, Robin J Svensson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band DosingBudi O Susanto, Robin J Svensson, Elin M Svensson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 4, 2022
Rituximab pharmacokinetic and pharmacokinetic-pharmacodynamic evaluation based on a study in diffuse large B-cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarityRobin J Svensson, Qing Xi Ooi, Lena E Friberg, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosisRobin J Svensson, Katarina Niward, Lina Davies Forsman, et al.
Clinical Pharmacology and Therapeutics|June 28, 2017
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin DosesRobin J Svensson, Rob E Aarnoutse, Andreas H Diacon, et al.
Clinical Pharmacology and Therapeutics|April 28, 2018
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With RifampicinSebastian G Wicha, Oskar Clewe, Robin J Svensson, et al.
Pageof 2